Study Seeking to Enroll 222 Patients; Largest Vaccine Trial Ever Funded by NCI in Brain Tumors and the Largest Cancer Vaccine Study Ever Conducted in Combination With Avastin LEXINGTON, Mass., May 22,... Continue Reading

Tumors resistant to Zelboraf® (vemurafenib) in patients with melanoma showed reduced growth after treatment was stopped. What’s more—animal models have shown that drug resistance was prevented by... Continue Reading

Among women with metastatic, HER2-positive breast cancer, those with the highest tumor HER2 levels benefit the most from the drug Kadcyla™ (ado-trastuzumab emtansine, formerly known as T-DM1), according... Continue Reading

A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association... Continue Reading

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading

For Immediate Release May 14, 2013 UCSF Launches Social Networking Site for Patients and Families with Hereditary Cancers San Francisco, CA—Genetic counselors at UCSF have created KinTalk.org,... Continue Reading